Editorial: Cognitive and Behavioral Features in ALS: Beyond Motor Impairment in ALS-FTD Spectrum Disorders

Editorial: Cognitive and Behavioral Features in ALS: Beyond Motor Impairment in ALS-FTD Spectrum Disorders

Bibliographic Details
Main Authors:	Enrica Bersano, Umberto Manera, William Huynh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Neurology
Subjects:	cognitive and behavioral features ALS (amyotrophic lateral sclerosis) frontotemporal dementia (FTD) spectrum review and editing biomarker Motor neuron disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.891841/full

Similar Items

Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD
by: Claudia Fallini, et al.
Published: (2020-07-01)

Neural circuit and synaptic dysfunctions in ALS-FTD pathology
by: Santiago Mora, et al.
Published: (2023-07-01)

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD
by: Tariq Afroz, et al.
Published: (2023-04-01)

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of Proteomics
by: Francesca Vignaroli, et al.
Published: (2023-01-01)

Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum
by: Yalda Baradaran-Heravi, et al.
Published: (2020-02-01)

Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells
by: Wenting Guo, et al.
Published: (2017-12-01)

Thalamic and Cerebellar Regional Involvement across the ALS–FTD Spectrum and the Effect of <i>C9orf72</i>
by: Martina Bocchetta, et al.
Published: (2022-03-01)

The association between lifelong personality and clinical phenotype in the FTD-ALS spectrum
by: Giulia Vinceti, et al.
Published: (2023-10-01)

Emerging perspectives of synaptic biomarkers in ALS and FTD
by: Karrthik Krishnamurthy, et al.
Published: (2024-01-01)

Cytoplasmic Expression of the ALS/FTD-Related Protein TDP-43 Decreases Global Translation Both in vitro and in vivo
by: Santiago E. Charif, et al.
Published: (2020-12-01)

Distinct Phospho-TDP-43 brain distribution in two cases of FTD, one associated with ALS
by: Álvaro C.B. Guedes, et al.

Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage
by: Emma M. Devenney, et al.
Published: (2021-11-01)

Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease
by: Pauline A. Gelon, et al.
Published: (2022-10-01)

The era of cryptic exons: implications for ALS-FTD
by: Puja R. Mehta, et al.
Published: (2023-03-01)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
by: Thomas J. Hedl, et al.
Published: (2019-06-01)

Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition
by: Mari Carmen Pelaez, et al.
Published: (2023-11-01)

Exome Sequencing of a Portuguese Cohort of Frontotemporal Dementia Patients: Looking Into the ALS-FTD Continuum
by: Miguel Tábuas-Pereira, et al.
Published: (2022-07-01)

Linking hnRNP Function to ALS and FTD Pathology
by: Maria D. Purice, et al.
Published: (2018-05-01)

Editorial: What's next? Innovative translational markers across the ALS-FTD continuum
by: Fabiola De Marchi, et al.
Published: (2023-08-01)

Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
by: Xiaoqiang Tang, et al.
Published: (2020-06-01)

Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
by: Fabiola De Marchi, et al.
Published: (2023-05-01)

C9ORF72 and the FTD-ALS spectrum: a systematic review of neuroimaging studies
by: Laura de Godoy Rousseff Prado, et al.

C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice
by: Maria-Belen Lopez-Herdoiza, et al.
Published: (2023-04-01)

Clinical and neuropathological features of ALS/FTD with TIA1 mutations
by: Veronica Hirsch-Reinshagen, et al.
Published: (2017-12-01)

Case report: Asp194Ala variant in MFN2 is associated with ALS-FTD in an Italian family
by: C. Vinciguerra, et al.
Published: (2023-07-01)

Neuroprotective activity of ursodeoxycholic acid in CHMP2BIntron5 models of frontotemporal dementia
by: Ryan J.H. West, et al.
Published: (2020-10-01)

Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
by: Bilal Khalil, et al.
Published: (2024-01-01)

Moving Toward Patient-Tailored Treatment in ALS and FTD: The Potential of Genomic Assessment as a Tool for Biological Discovery and Trial Recruitment
by: Iris J. Broce, et al.
Published: (2021-03-01)

Novel data-driven subtypes and stages of brain atrophy in the ALS–FTD spectrum
by: Ting Shen, et al.
Published: (2023-12-01)

DNA Damage and Repair Deficiency in ALS/FTD-Associated Neurodegeneration: From Molecular Mechanisms to Therapeutic Implication
by: Haibo Wang, et al.
Published: (2021-12-01)

The Characteristics of Cognitive Impairment in ALS Patients Depend on the Lateralization of Motor Damage
by: Umberto Manera, et al.
Published: (2020-09-01)

G‐quadruplex‐binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo
by: Roberto Simone, et al.
Published: (2017-11-01)

Breakdown of the central synapses in C9orf72-linked ALS/FTD
by: Layla T. Ghaffari, et al.
Published: (2022-09-01)

Impairments of inhibitory neurons in amyotrophic lateral sclerosis and frontotemporal dementia
by: Félicie Lorenc, et al.
Published: (2024-12-01)

Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia
by: Xunzhe Yang, et al.
Published: (2022-11-01)

Phenotyping C9-ALS/FTD iPSC-derived cortical neurons
by: Graf, MS
Published: (2023)

Molecular Mechanisms Linking ALS/FTD and Psychiatric Disorders, the Potential Effects of Lithium
by: Fiona Limanaqi, et al.
Published: (2019-10-01)

Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement
by: Robert Rusina, et al.
Published: (2021-03-01)

A comparative bioinformatic analysis of C9orf72
by: Shalini Iyer, et al.
Published: (2018-02-01)

Poly‐GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD
by: Carina Lehmer, et al.
Published: (2017-04-01)